Dr. Reddy's Laboratories Limited (BVMF:R1DY34)
Brazil
· Delayed Price · Currency is BRL 11.96
-0.64 (-5.08%)
At close: Nov 7, 2025
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2005 - 2019 |
| Global Generics | 289.55B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Global Generics Growth | 17.97% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Services and Active Ingredients | 33.85B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Services and Active Ingredients Growth | 13.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 2.14B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -45.35% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Proprietary Products | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Proprietary Products Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 2.14B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -45.35% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2005 - 2019 |
| Other | 94.40B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 29.62% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | 149.35B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 10.17% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| India | 55.83B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| India Growth | 15.18% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Russia | 25.96B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Russia Growth | 16.40% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 94.40B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 29.62% |
Log In |
Log In |
Log In |
Log In | Upgrade
|